Patent · US Active

Soluble C5aR antagonists

US10329314B2 · kind B2 · utility

11Cited by

3References

21Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Pingchen Fan · Fremont, US
Antoni Krasinski · San Jose, US
Venkat Reddy Mali · Cupertino, US
Shichang Miao · Foster City, US
Sreenivas Punna · Sunnyvale, US
Yang Song · Kunming, CN
Valentino J. Stella · Lawrence, US
Yibin Zeng · Foster City, US
Penglie Zhang · Foster City, US

Key dates

Filing date	Feb 28, 2018
Grant date	Jun 25, 2019
Priority date	—
Expiry date	Feb 28, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/59
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.